Updates are available Correction dated 2021-03-03
Click to view Correction: https://doi.org/10.1007/s10147-021-01880-5
-
Authors
Otsuka, Taiga
Shirakawa, Tsuyoshi https://orcid.org/0000-0002-9317-8216
Shimokawa, Mototsugu
Koga, Futa
Kawaguchi, Yasunori
Ueda, Yujiro
Nakazawa, Junichi
Komori, Azusa
Otsu, Satoshi
Arima, Shiho
Fukahori, Masaru
Okabe, Yoshinobu
Makiyama, Akitaka
Taguchi, Hiroki
Honda, Takuya
Shibuki, Taro
Nio, Kenta
Ide, Yasushi
Mizuta, Toshihiko
Mitsugi, Kenji
Ureshino, Norio
- License Information
-
More Information
Article History
Received: 28 August 2020
Accepted: 20 December 2020
First Online: 23 January 2021
Change Date: 3 March 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10147-021-01880-5
Compliance with ethical standards
:
: T.O. received grant from Chugai; T.S. received consulting fees from Taiho Pharmaceutical, Chugai, and Takeda; M.S. received personal fee from Sysmex Corporation; Y.K. received personal fee from Taiho Pharmaceutical; S.A. received personal fees from Taiho Pharmaceutical, Novartis Pharma, Chugai, Bristol-Myers Squibb, Daiichi-Sankyo, and AstraZeneka; A.M. received personal fees from Eli Lilly, Chugai, and Takeda. The remaining authors have no competing interests or financial disclosures to declare.
: This study was approved by the institutional review board or ethics committee of each participating institution prior to the study, and conducted according to the Declaration of Helsinki.
: The requirement for consent to participate was waived because of the retrospective design of this study.
: The requirement for consent for publication was waived because of the retrospective design of this study.
